BRIACELL THERAP (BCTX)
(Delayed Data from NSDQ)
$0.68 USD
+0.05 (8.49%)
Updated Aug 7, 2025 04:00 PM ET
After-Market: $0.68 0.00 (-0.51%) 7:58 PM ET
3-Hold of 5 3
C Value F Growth C Momentum D VGM
Fundamental Charts
About Dividend Yield (TTM)
BRIACELL THERAP's dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
BCTX 0.68 +0.05(8.49%)
Will BCTX be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for BCTX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for BCTX
BRIACELL THERAP (BCTX) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
BRIACELL THERAP (BCTX) Upgraded to Buy: What Does It Mean for the Stock?
BCTX: What are Zacks experts saying now?
Zacks Private Portfolio Services
What Makes BRIACELL THERAP (BCTX) a New Strong Buy Stock
Other News for BCTX
BriaCell Announces Proposed Effective Date of Share Consolidation | BCTX Stock News
BriaCell (BCTX) Expands Phase 3 Breast Cancer Study with UCLA Health
BriaCell Adds UCLA Health as Key Site in Pivotal Phase 3 Breast Cancer Study | BCTX Stock News
BriaCell adds UCLA Health as site in Phase 3 breast cancer study
BriaCell (BCTX) Secures New Zealand Patent for Innovative Cancer Vaccine